Salmeterol is a selective long-acting bronchodilator indicated for the regular symptomatic treatment of reversible airways obstruction in patients with asthma, including those with nocturnal asthma or chronic obstructive pulmonary disease (COPD). SEREVENT Inhaler may also be used for the prevention of exercise-induced asthma.
For patients with asthma, it is indicated for those treated with inhaled corticosteroids who require a long-acting beta-agonist.
SEREVENT Inhaler is not a replacement for inhaled or oral corticosteroids which should be continued at the same dose, and not stopped or reduced, when treatment with SEREVENT Inhaler is initiated.